List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #911 to #960.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. APPROACH → Assessment On The Prevention Of Progression By Rosiglitazone On Atherosclerosis In Diabetes Patients With Cardiovascular History
  2. APRES → Angiotensin-Converting Enzyme Inhibition Post Revascularization Study
  3. APRICOT → Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis
  4. APRICOT-2 → Antithrombotics In The Prevention Of Reocclusion In Coronary Thrombolysis-2
  5. APS1 → Autoimmune polyendocrine syndrome
  6. APS 1 → Autoimmune polyendocrine syndrome
  7. APS type 1 → Autoimmune polyendocrine syndrome
  8. APS type 2 → Autoimmune polyendocrine syndrome
  9. APS type 3 → Autoimmune polyendocrine syndrome
  10. APT → Amiodarone pulmonary toxicity
  11. APTT → Partial thromboplastin time
  12. APTX → Aprataxin
  13. APUDoma of skin → Merkel cell cancer
  14. APUDoma of the skin → Merkel cell cancer
  15. AP endonucleases → AP endonuclease
  16. AQP1 → Aquaporin 1
  17. AR → Aortic regurgitation
  18. AR-CMT2 → Charcot-Marie-Tooth Syndrome
  19. ARB → Angiotensin II receptor antagonist
  20. ARBITER 2 → Arterial Biology For The Investigation Of The Treatment Effects Of Reducing Cholesterol 2
  21. ARBs → Angiotensin II receptor antagonist
  22. ARCH → Amiodarone Reduction In Coronary Heart Trial
  23. ARCHeR → For Revascularization Of Carotids In High-Risk Patients
  24. ARDS → Acute respiratory distress syndrome
  25. AREDS → Age-Related Eye Disease Study
  26. ARF → Acute kidney injury
  27. ARG-911 → Argatroban-911
  28. ARG-915 → Argatroban-915
  29. ARGAMI-2 → Argatroban For Acute Myocardial Infarction
  30. ARIC → Atherosclerosis Risk In Communities
  31. ARIES 1 and 2 → Ambrisentan In Pulmonary Arterial Hypertension Efficacy Study 1 And 2
  32. ARISE → Aggressive Reduction Of Inflammation Stops Events
  33. ARI Sodium Iodide (I123) 1-12 MBq → Sodium iodide
  34. ARI Sodium Iodide (I123) 100-750 MBq → Sodium iodide
  35. ARMS → Apsac Reocclusion Multicenter Study
  36. ARMYDA → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty
  37. ARMYDA-2 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 2
  38. ARMYDA-3 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 3
  39. ARMYDA-4 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 4
  40. ARMYDA-5 → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty 5
  41. ARMYDA-ACS → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Acute Coronary Syndromes
  42. ARMYDA-RECAPTURE → Atorvastatin For Reduction Of Myocardial Damage During Angioplasty-Recapture
  43. ARMYDA-RELOAD → Antiplatelet Therapy For Reduction Of Myocardial Damage During Angioplasty-Reload
  44. ARNT gene → Aryl hydrocarbon receptor nuclear translocator
  45. ARPEGGIO → Rimonabant Improves Glycemic Control In Insulin-Treated Type 2 Diabetes
  46. ARPKD → Polycystic kidney disease
  47. ARR → Absolute risk reduction
  48. ART → AIDS antiretroviral drugs
  49. ARTIST → Angioplasty Versus Rotational Atherectomy For Treatment Of Diffuse In-Stent Restenosis Trial
  50. ARTISTIC → Angiorad Radiation Therapy For In-Stent Restenosis Intracoronary

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"